HOW CAN WE HELP YOU? Call 1-800-TRY-CHOP
CuRED News & Announcements
Displaying announcements from the past three years.
1 - 7 of 7
Published on Dec 8, 2023 in Press Releases
The Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel) and LYFGENIA™ (lovotibeglogene autotemcel), the first two gene therapies for the treatment of sickle cell disease in patients 12 years and older with recurrent vaso-occlusive crises.
Published on Jul 31, 2023 in Cornerstone Blog
Researchers developed a proof-of-concept model for delivering gene editing tools to treat blood disorders, allowing for the modification of diseased blood cells directly within the body.
Published on Sep 9, 2022 in Cornerstone Blog
In this Q&A, hematologist Dr. Kwiatkowski discusses the Food and Drug Administration approval of beti-cel (Zynteglo®), a gene therapy for beta thalassemia.
Published on Mar 28, 2022 in Cornerstone Blog
The Susan S. and Stephen P. Kelly Center for Cancer Immunotherapy is a first-of-its-kind hub for pediatric Cancer Immunotherapy.
Published on Jun 2, 2021 in Cornerstone Blog
Stefano Rivella, PhD, is developing a new gene therapy — a multitasking vector — for treatment of red blood disorders.
Published on Feb 1, 2021 in Cornerstone Blog
CHOP researchers have developed a potentially safer and more effective gene therapy vector for red blood disorders.
Published on Jan 29, 2021 in Press Releases
Researchers developed a gene therapy vector for blood disorders that is potentially safer and more effective than those currently in use.